Measuring access associated with NICE technology appraisal decisions
Do NICE decisions affect decisions in other countries?
Opportunity costs of implementing NICE decisions in NHS Wales
Are the UK systems of innovation and evaluations of medical devices compatible?
Amanda Chapman, C. A. Taylor (University of Birmingham) and A. J. Girling (University of Birmingham)
A Cost-effectiveness Analysis of Interventions for Symptomatic Varicose Veins
Grace Marsden, M. Perry, A. Bradbury, N. Hickey, K. Kelley, H. Trender, D. Wonderling and A. H. Davies
What Is the Appropriate Comparator Health State to Use in Time Trade-off Studies?
Koonal Shah and Brendan Mulhern (University of Sheffield)
The Expanding Value Footprint of Oncology Treatments.
Posted in Health Technology Assessment, Innovation, NICE, Value-Based Pricing | Tagged Presentations